Insiders · AEON

AEON insider transactions

AEON Biopharma Inc. (AEON) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for AEON

• 23d
  SEC Form 4 filed by Bencich John

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 23d
  SEC Form 3 filed by new insider Bencich John

  3 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 46d
  CHIEF MEDICAL OFFICER Oh Chad was granted 2,179,372 shares, increasing direct ownership by 53,626% to 2,183,436 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 52d
  CLO, CSO, and Corp Secretary Wilson Alexander Blair was granted 2,179,372 shares, increasing direct ownership by 59,988% to 2,183,005 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 52d
  PRINCIPAL ACCOUNTING OFFICER Sy Jennifer was granted 1,500,925 shares, increasing direct ownership by 597,978% to 1,501,176 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 66d
  PRESIDENT & CEO Bancroft Robert E. was granted 3,000,000 shares, increasing direct ownership by 1,694% to 3,177,103 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 87d
  New insider Daewoong Co., Ltd claimed ownership of 12,009,737 shares (SEC Form 3)

  3 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Director Thunen Shelley B

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Exec VP, CLO & Corp Secretary Wilson Alexander Blair

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Chief Medical Officer Oh Chad

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Chief Accounting Officer Sy Jennifer

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Director Forth Marc

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Director Palmisano Robert J

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Director Carter Eric G

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  SEC Form 4 filed by Director Fischer Jost

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 338d
  Director Fischer Jost bought $29,250 worth of shares (60,000 units at $0.49), increasing direct ownership by 29% to 266,785 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 340d
  Director Fischer Jost bought $55,300 worth of shares (110,000 units at $0.50), increasing direct ownership by 114% to 206,785 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 345d
  President & CEO Bancroft Robert E. was granted 177,103 shares (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 360d
  SEC Form 4 filed by President & CEO Bancroft Robert E.

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 360d
  SEC Form 3 filed by new insider Bancroft Robert E.

  3 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 593d
  Amendment: Director Palmisano Robert J was granted 36,021 shares (SEC Form 4)

  4/A - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  PRINCIPAL ACCOUNTING OFFICER Sy Jennifer was granted 18,010 shares (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  Director Carter Eric G was granted 36,021 shares (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  Director Fischer Jost was granted 36,021 shares, increasing direct ownership by 59% to 96,785 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  EXEC VP, CLO & CORP SECRETARY Wilson Alexander Blair was granted 180,110 shares, increasing direct ownership by 221% to 261,538 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  CHIEF EXECTUIVE OFFICER Forth Marc was granted 470,692 shares, increasing direct ownership by 168% to 750,547 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  CHIEF MEDICAL OFFICER Oh Chad was granted 192,117 shares, increasing direct ownership by 191% to 292,545 units (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  Director Thunen Shelley B was granted 36,021 shares (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 599d
  Director Palmisano Robert J was granted 36,021 shares (SEC Form 4)

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 702d
  SEC Form 3 filed by new insider Sy Jennifer

  3 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 738d
  SEC Form 3 filed by new insider Park Seongsoo

  3 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 740d
  SEC Form 4 filed by Daewoong Co., Ltd (Amendment)

  4/A - AEON Biopharma, Inc. (0001837607) (Issuer)
• 744d
  SEC Form 4 filed by Daewoong Co., Ltd

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 761d
  SEC Form 4 filed by Daewoong Co., Ltd

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 766d
  SEC Form 4 filed by Thunen Shelley B

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 766d
  SEC Form 4 filed by Palmisano Robert J

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 766d
  SEC Form 4 filed by Forth Marc

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 766d
  SEC Form 4 filed by Oh Chad

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 766d
  SEC Form 4 filed by Fischer Jost

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 766d
  SEC Form 4 filed by Carter Eric G

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)
• 766d
  SEC Form 4 filed by Wilson Alexander Blair

  4 - AEON Biopharma, Inc. (0001837607) (Issuer)